241 related articles for article (PubMed ID: 32737652)
1. BAX-dependent mitochondrial pathway mediates the crosstalk between ferroptosis and apoptosis.
Lee YS; Kalimuthu K; Park YS; Luo X; Choudry MHA; Bartlett DL; Lee YJ
Apoptosis; 2020 Oct; 25(9-10):625-631. PubMed ID: 32737652
[TBL] [Abstract][Full Text] [Related]
2. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Bid in the crosstalk between ferroptotic agent-induced ER stress and TRAIL-induced apoptosis.
Kim JH; Najy AJ; Li J; Luo X; Kim HC; Choudry MHA; Lee YJ
J Cell Physiol; 2022 Nov; 237(11):4180-4196. PubMed ID: 35994698
[TBL] [Abstract][Full Text] [Related]
4. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.
Deng Y; Lin Y; Wu X
Genes Dev; 2002 Jan; 16(1):33-45. PubMed ID: 11782443
[TBL] [Abstract][Full Text] [Related]
5. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.
Jelínková I; Šafaříková B; Vondálová Blanářová O; Skender B; Hofmanová J; Sova P; Moyer MP; Kozubík A; Kolář Z; Ehrmann J; Hyršlová Vaculová A
Biochem Pharmacol; 2014 Dec; 92(3):415-24. PubMed ID: 25285768
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells.
Han J; Goldstein LA; Gastman BR; Rabinovitz A; Wang GQ; Fang B; Rabinowich H
Leukemia; 2004 Oct; 18(10):1671-80. PubMed ID: 15356645
[TBL] [Abstract][Full Text] [Related]
7. Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression.
Hong SH; Lee DH; Lee YS; Jo MJ; Jeong YA; Kwon WT; Choudry HA; Bartlett DL; Lee YJ
Oncotarget; 2017 Dec; 8(70):115164-115178. PubMed ID: 29383150
[TBL] [Abstract][Full Text] [Related]
8. Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway.
von Haefen C; Gillissen B; Hemmati PG; Wendt J; Güner D; Mrozek A; Belka C; Dörken B; Daniel PT
Oncogene; 2004 Oct; 23(50):8320-32. PubMed ID: 15467752
[TBL] [Abstract][Full Text] [Related]
9. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
Wang S; El-Deiry WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
[TBL] [Abstract][Full Text] [Related]
10. Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis.
He Q; Montalbano J; Corcoran C; Jin W; Huang Y; Sheikh MS
Oncogene; 2003 May; 22(17):2674-9. PubMed ID: 12730681
[TBL] [Abstract][Full Text] [Related]
11. Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells.
Hemmati PG; Güner D; Gillissen B; Wendt J; von Haefen C; Chinnadurai G; Dörken B; Daniel PT
Oncogene; 2006 Oct; 25(50):6582-94. PubMed ID: 16847458
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK.
Ling YH; Lin R; Perez-Soler R
Mol Pharmacol; 2008 Sep; 74(3):793-806. PubMed ID: 18524889
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation.
Kim M; Park SY; Pai HS; Kim TH; Billiar TR; Seol DW
Cancer Res; 2004 Jun; 64(12):4078-81. PubMed ID: 15205314
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.
Lee YS; Lee DH; Jeong SY; Park SH; Oh SC; Park YS; Yu J; Choudry HA; Bartlett DL; Lee YJ
J Cell Biochem; 2019 Jan; 120(1):928-939. PubMed ID: 30160785
[TBL] [Abstract][Full Text] [Related]
15. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.
Hu H; Jiang C; Schuster T; Li GX; Daniel PT; Lü J
Mol Cancer Ther; 2006 Jul; 5(7):1873-82. PubMed ID: 16891474
[TBL] [Abstract][Full Text] [Related]
16. Glucose deprivation-induced endoplasmic reticulum stress response plays a pivotal role in enhancement of TRAIL cytotoxicity.
Kalimuthu K; Kim JH; Park YS; Luo X; Zhang L; Ku JL; Choudry MHA; Lee YJ
J Cell Physiol; 2021 Sep; 236(9):6666-6677. PubMed ID: 33586156
[TBL] [Abstract][Full Text] [Related]
17. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
He Q; Luo X; Huang Y; Sheikh MS
Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
[TBL] [Abstract][Full Text] [Related]
18. TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway.
Wendt J; von Haefen C; Hemmati P; Belka C; Dörken B; Daniel PT
Oncogene; 2005 Jun; 24(25):4052-64. PubMed ID: 15806163
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K.
Sundararajan R; Cuconati A; Nelson D; White E
J Biol Chem; 2001 Nov; 276(48):45120-7. PubMed ID: 11571294
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells.
He Q; Huang Y; Sheikh MS
Oncogene; 2004 Apr; 23(14):2554-8. PubMed ID: 14691451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
